[Activity Report] The 11th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (October 23, 2024)
date : 11/7/2024
Tags: AMR
The AMR Consortium of the Asia Africa Medical Innovation Consortium, for which AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) serves as the secretariat, discussed innovation needed to address antimicrobial resistance (AMR) during the “Agenda4 Innovation” in the 11th NIKKEI FT Communicable Diseases Conference, organized by Nikkei Inc. and co-organized by THE FINANCIAL TIMES LTD.
During the meeting, AMR Consortium Co-Chair Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University School of Medicine) shared his views on potential innovative solutions to combat AMR, including advancements in the field of drug discovery, vaccine development, bacteriophage therapy, diagnostic methods, approaches utilizing bacterial flora, as well as antibody drugs. He also reflected on the achievements of the AMR Consortium’s activities and policy development on AMR. The pressing need for a pull-type incentive system and the establishment of a drug discovery ecosystem that contributes to infection control measures were also mentioned during the discussion, and participants agreed on its importance and urgency.
[Overview]
- Date: Wednesday, October 23, 2024
- Program: Agenda4 Innovation

Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)



